ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKG:1541)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
13.98
+1.68 (13.66%)
Sep 5, 2025, 4:08 PM HKT

Revenue by Product

Fiscal year is January - December.
Year Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Out-Licensing Fee
77.35M
Log In
Log In
Log In
Log In
Collaboration Development
2.89M
Log In
Log In
Log In
Log In
Cell Strain and Other Products
120.35K
Log In
Log In
Log In
Log In
Cell Strain and Other Products Growth
-70.32%
Log In
Log In
Log In
Log In
Testing Services
30.36K
Log In
Log In
Log In
Log In
Testing Services Growth
44.60%
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Year Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
China
80.39M
Log In
Log In
Log In
Log In
China Growth
18748.44%
Log In
Log In
Log In
Log In